Medicare Compliance & Reimbursement - 2005 Issue 42
PHARMACEUTICALS: Part D Fraud A Priority For CMS
Subscribe or sign in to view the full article.
Article Overview
This article covers CMS efforts to prepare for fraud detection and complaint investigations ahead of the Medicare prescription drug benefit. It is intended for providers, beneficiaries, Medicare prescription drug plans, and compliance-focused readers who want a high-level view of CMS oversight, contractor activity, and marketing enforcement concerns surrounding Part D.
Why This Topic Matters
It helps readers understand the general compliance and fraud-prevention environment around Medicare Part D and why CMS was emphasizing monitoring, contractor support, and enforcement activity.
What You Will Learn
- What CMS was preparing for in connection with Medicare Part D fraud oversight
- Which types of groups CMS expected to help identify suspicious activity
- What broad contractor functions CMS highlighted for fraud detection and investigation
- Why marketing and enrollment oversight was being emphasized
Who Should Read This
- Providers
- Beneficiaries
- Medicare prescription drug plans
- Compliance professionals
- Health care administrators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com